FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to molecular biology, biochemistry and medicine. What is presented is an L-nucleic acid that is a MCP-1 antagonist, and a method for detecting it.
EFFECT: invention may be used in treating the diseases caused by MCP-1 pathogenesis mechanism.
16 cl, 50 dwg, 1 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MCP-1 BINDING NUCLEIC ACID AND USING IT | 2008 |
|
RU2542973C2 |
| CXCL8-BINDING NUCLEIC ACIDS | 2019 |
|
RU2815444C2 |
| SDF-1 BINDING NUCLEIC ACIDS AND USE THEREOF | 2008 |
|
RU2612388C2 |
| SDF-1 BINDING NUCLEIC ACIDS | 2007 |
|
RU2590709C2 |
| ANTI-CCR2 ANTIBODIES | 2009 |
|
RU2547595C2 |
| ANTIKINE ANTIBODIES BINDING TO SEVERAL CC-CHEMOKINES | 2010 |
|
RU2574786C2 |
| SDF1-BINDING NUCLEIC ACIDS AND USE THEREOF IN CANCER TREATMENT | 2011 |
|
RU2679495C2 |
| MEANS FOR INHIBITING PROTEINKINASE 3 EXPRESSION | 2007 |
|
RU2553561C2 |
| METHOD FOR POLYALKOXYLATING NUCLEIC ACIDS, ALLOWING FOR EXTRACTION AND REUSE OF EXCESS POLYALKOXYLATING REAGENT | 2017 |
|
RU2765027C2 |
| DNA COMPOSITION FOR INDUCING IMMUNE RESPONSE ON TUMOUR-ASSOCIATED MACROPHAGUES | 2007 |
|
RU2459631C2 |
